✦ LIBER ✦

Pharmacology of JNJ-37822681, a Specific and Fast-Dissociating D2 Antagonist for the Treatment of Schizophrenia

✍ Scribed by Langlois, X.; Megens, A.; Lavreysen, H.; Atack, J.; Cik, M.; te Riele, P.; Peeters, L.; Wouters, R.; Vermeire, J.; Hendrickx, H.; Macdonald, G.; De Bruyn, M.

Book ID: 118280091
Publisher: American Society for Pharmacology and Experimental Therapeutics
Year: 2012
Tongue: English
Weight: 611 KB
Volume: 342
Category: Article
ISSN: 0022-3565
DOI: 10.1124/jpet.111.190702

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.d.009 Pharmacology of JNJ-37822681,

P.3.d.009 Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia

✍ X. Langlois; A. Megens; H. Lavreysen; R. Wouters; L. Peeters; P. te Riele; H. He 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P.3.c.046 Efficacy and safety of JNJ 378

P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophrenia

✍ M. Schmidt; L. Janssens; J. Kent; I. Anghelescu; G. Hüsken; V. Sinha; E. Mannaer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P.3.a.026 Safety, tolerability and D2 oc

P.3.a.026 Safety, tolerability and D2 occupancy of the fast dissociating D2 antagonist JNJ-37822681 in healthy subjects

✍ M. Schmidt; P. de Boer; E. Mannaert; T. Iersel; L. van Nueten 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Pharmacokinetics and central nervous sys

Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681

✍ te Beek, E. T.; Moerland, M.; de Boer, P.; van Nueten, L.; de Kam, M. L.; Burggr 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 295 KB

D2-receptor occupancy measurement of JNJ

D2-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D2-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selection

✍ Mark E. Schmidt, Peter de Boer, Randolph Andrews, Martine Neyens… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 277 KB

Zuclopenthixol, D1/D2 antagonist, for tr

Zuclopenthixol, D1/D2 antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients

✍ A Grinshpoon; M Moskowitz; A Valevski; A Kreizman; L Palei; M Mar; A Weizman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 French ⚖ 244 KB